September

Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis

University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous fluids and hospital admissions in children with acute gastroenteritis.

Nearly half of U.S. adults will develop painful knee osteoarthritis by age 85: study

Almost half of all U.S. adults and nearly two-thirds of obese adults will develop painful osteoarthritis of the knee by age 85, a study based at the University of North Carolina at Chapel Hill suggests.

Laser surgery better than steroid injections for preserving eyesight in diabetics

Newly published results from a clinical trial show that laser surgery is more effective at preserving eyesight in diabetics and has fewer side effects than steroid injections.

UNC scientists, research network, unveil results from groundbreaking brain tumor study

A nationwide team of scientists, including researchers at the University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center, have reported the first results of a large-scale, comprehensive study of the most common form of brain cancer, glioblastoma.

UNC spin-off company receives $2 million grant to market cancer treatment technology

A University of North Carolina at Chapel Hill spin-off company has been awarded a $2 million grant to commercialize a new technology to improve radiation treatment of prostate cancer.

Investment in imaging to accelerate UNC researchers' understanding of disease

Initial site preparation is under way for the seven-story, 343,000-square-foot Imaging Research Center, which will house the Biomedical Research Imaging Center (BRIC), research labs and a consortium and facility designed to support and advance the rapidly developing science of biomedical imaging.

First generation antipsychotic drugs as effective as newer ones in some children

A new study from the University of North Carolina at Chapel Hill School of Medicine suggests that molindone, a first-generation drug, is as effective as the newer ones and should be used as a first line of therapy in some children with schizophrenia or schizoaffective disorder.

UNC, WPIC to conduct Internet-based study of cognitive behavioral therapy for bulimia

The University of North Carolina at Chapel Hill is leading a novel clinical trial to compare the effectiveness of online cognitive behavioral therapy, delivered through a Web site and augmented with therapist-moderated, weekly online chat sessions, to face-to-face group therapy for the treatment of bulimia nervosa.

UNC researcher receives EUREKA award from NIH

Brian D. Strahl, Ph.D., associate professor of biochemistry and biophysics at the University of North Carolina at Chapel Hill School of Medicine, is one of 38 scientists nationally to receive the first grants in a new federal program called EUREKA (Exceptional, Unconventional Research Enabling Knowledge Acceleration).

UNC scientists turn human skin cells into insulin-producing cells

Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes.

UNC study: no need to repeat colonoscopy until 5 years after first screening

Among people who have had an initial colonoscopy that found no polyps, a possible sign of cancer, the risk of developing colorectal cancer within five years is extremely low, a new study has found.

UNC radiation oncologist receives national honor

Joel E. Tepper, M.D., professor of radiation oncology at the University of North Carolina at Chapel Hill School of Medicine, is being honored by the American Society of Therapeutic Radiology (ASTRO) as one of two recipients of the organization’s Gold Medal Award.

UNC researchers to take part in multi-center, $8.9 million study of childhood hearing loss

University of North Carolina at Chapel Hill researchers will play a key role in a five-year, $8.9 million study aimed at understanding the impact hearing loss can have on children’s ability to communicate, succeed in school, and have good social and psychological development.

New UNC gastrointestinal cancer clinical trials funded

The UNC Lineberger Comprehensive Cancer Center has received a two-year, $125,000 grant to support clinical trials in gastrointestinal (GI) cancers.